| PROGRAMME | |
| DAY ONE (21 September 2015) |
| 08:30 | Registration |
| 09:00 | Introduction |
| 09:15 | Recent trends and the future of pharmaceutical packaging technology: regulator’s perspective |
| 10:00 | Morning Refreshments |
| 10:15 | Guidance for industry on standards for sterile drug products produced by aseptic processing: possibility of errors, validation and control |
| 11:00 | Improved manufacturing efficiency and process control in decontamination and depyrogenation of the critical fill zone shroud with BFS technology |
| 11:45 | Innovation in pharmaceutical packaging technology in order to minimize risks of microbiological, foreign particulate and pyrogen contamination |
| 12:30 | Lunch |
| 14:00 | Reducing the risk associated with the filling of biologics with advanced BFS aseptic technology |
| 14:45 | New technology for "glass-free delivery" of injectable drugs using BFS technology |
| 15:30 | Afternoon Refreshments |
| 15:45 | Pharmaceutical packaging, including some considerations for paediatric formulations |
| 16:30 | Panel Discussion |
| 17:00 | End of Day One |
| DAY TWO (22 September 2015) |
| 09:00 | Introduction |
| 09:15 | Regulatory science in pharmaceutical product lifecycle |
| 10:00 | Morning Refreshments |
| 10:15 | Enhancing BFS technologies and applications |
| 11:00 | The importance of leveraging BFS technology to bring new innovation to minimize inaccurate and poor dosing compliance |
| 11:45 | BFS technology and reducing the risk of microbial contamination and reduce the level of foreign particulates |
| 12:30 | Lunch |
| 14:00 | Promoting innovative drug delivery packaging solutions, including BFS capabilities in order to improve patient safety |
| 14:45 | New innovations in BFS technology and the future of BFS technology in decontamination and depryogenation processes |
| 15:30 | Afternoon Refreshments |
| 15:45 | Sterile ophthalmic preparations and contamination control |
| 16:30 | Panel discussion |
| 17:00 | End of Conference |
Recent trends and the future of pharmaceutical packaging technology in order to minimize risks of microbiological, particulate and pyrogen contamination that can ultimately pose a life threatening health risk to a patient, including discussion on reducing the risk associated with the filling of biologics with advanced BFS aseptic technology |
|
Packaging medications in a unit-dose format has been popular. BFS technology ensures preservative-free unit doses and easy to use unit-dose vials in particular for products requiring an accurate dose delivery as well as reduces human intervention which reduces the risk of microbial contamination and drastically reduces foreign particulates. BFS has long been used in liquid pharmaceutical applications, including small containers, such as ophthalmic and respiratory drug ampoules, as well as larger volume containers, such as saline or dextrose solutions. More recently, BFS technology has been expanding into injectables and biologics, including vaccines and monoclonal antibodies (mAbs). Against this development, World Pharmaceutical Blow-Fill-Seal (BFS) Technology Conference 2015, is a timely platform to discuss and promote the need for single unit dosage forms in drug development, innovative drug delivery packaging solutions, including BFS capabilities to reduce the number of emergency room visits for those accidentally given the wrong dosage and the risk for inaccurate dosing in order to improve patient safety. Discussion will also include revolutionizing risk management in aseptic manufacturing with advanced aseptic filling techniques that substantially reduce the leading causes of microbial and particulate contamination. |